---
title: "Long-COVID can hide in the body for years in scores of locations"
slug: "long-covid-can-hide-in-the-body-for-years-in-scores-of-locations"
aliases:
  - "/Long-COVID+can+hide+in+the+body+for+years+in+scores+of+locations+–+Sept+2023"
  - "/tiki-index.php?page_id=14669"
date: 2023-09-09
categories:
  - "Virus"
---



<!-- {maketoc Title=""} -->

---

#### SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)

Nature Immunology Sept 2023 https://doi.org/10.1038/s41590-023-01601-2

Amy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, Sara Cherry, Daniel S. Chertow, Helen E. Davies, Christopher L. Dupont, Steven G. Deeks, William Eimer, E. Wesley Ely, Alessio Fasano, Marcelo Freire, Linda N. Geng, Diane E. Griffin, Timothy J. Henrich, Akiko Iwasaki, David Izquierdo-Garcia, Michela Locci, Saurabh Mehandru, Mark M. Painter, Michael J. Peluso, …E. John Wherry 

##### Table of Contents

<img src="/attachments/d3.mock.jpg" alt="image" width="600">

Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the coronavirus SARS-CoV-2 after acute infection. Instead, replicating virus and/or viral RNA—potentially capable of being translated to produce viral proteins—persist in tissue as a ‘reservoir’. This reservoir could modulate host immune responses or release viral proteins into the circulation. Here we review studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in PASC samples. Mechanisms by which a SARS-CoV-2 reservoir may contribute to PASC pathology, including coagulation, microbiome and neuroimmune abnormalities, are delineated. We identify research priorities to guide the further study of a SARS-CoV-2 reservoir in PASC, with the goal that clinical trials of antivirals or other therapeutics with potential to clear a SARS-CoV-2 reservoir are accelerated.

##### Locations in the body

<img src="/attachments/d3.mock.jpg" alt="image" width="900">

##### Research suggesions

 **Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC** 

* Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? 

  * Is there a preference for persistence in certain cell or tissue types?

* Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?

* Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? 

  * Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? 

  * If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?

* Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?

* Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?

* Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?

* Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?

* Are neutralizing antibody responses qualitatively different in patients with PASC?

* By what mechanisms can SARS-CoV-2 evade immune detection? 

  * Do such mechanisms differ by cell or tissue type, or by viral variant? 

  * Do viral mutations and selection contribute to persistence?

* Can the spike protein travel via EVs into the bloodstream?

* Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?

* Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?

* Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?

* Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?

* Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?

  *  If so, is disruption a cause or consequence of PASC?

* Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? 

  * Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?

* Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?

 **[<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i>Download the PDF from VitaminDWiki ](/attachments/d3.mock.pdf)** 

---

#### VitaminDWiki - <a href="/posts/long-covid-is-now-the-biggest-covid-concern-many-studies" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Long-COVID is now the biggest COVID concern - many studies">Long-COVID is now the biggest COVID concern - many studies</a>

---

---

#### VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on

---

##### VitaminDWiki -  
<!-- {SQL(db=>vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) > 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = "wiki page"{SQL} -->
       studies in both categories Virus and Vitamin D Receptor

This list is automatically updated

---

##### VitaminDWiki - [Vitamin D Receptor](/categories/vitamin-d-receptor) activation can be increased in 14 ways

 **[Resveratrol](/categories/resveratrol), &nbsp;<a href="/posts/overview-omega-3-many-benefits-include-helping-vitamin-domega-3" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Overview: Omega-3 many benefits include helping vitamin D|Omega-3">Overview: Omega-3 many benefits include helping vitamin D|Omega-3</a>, &nbsp;<a href="/posts/magnesium-and-vitamin-d-magnesium" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Magnesium and Vitamin D |Magnesium">Magnesium and Vitamin D |Magnesium</a>,&nbsp; <a href="/posts/zinc-and-vitamin-d-zinc" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Zinc and Vitamin D |Zinc">Zinc and Vitamin D |Zinc</a>, &nbsp; <a href="/posts/quercetin-flavonoid-helps-activate-the-vitamin-d-receptor-march-2016-quercetin" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin">Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin</a>, &nbsp; <a href="/posts/better-than-dailynon-daily-vit-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Better than Daily|non-daily Vit D">Better than Daily|non-daily Vit D</a>, &nbsp;<a href="/posts/curcumin-may-increase-vitamin-d-in-tissues-activates-vitamin-d-receptor-dec-2010curcumin" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin">Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin</a>, intense exercise, <a href="/posts/14th-activator-of-the-vitamin-d-receptor-butyrate-from-gut-bacteria-or-supplement-butyrate" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: 14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate">14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate</a> &nbsp; Ginger, &nbsp; Essential oils, etc&nbsp; Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators** 

<!-- ~tc~ (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) ~/tc~ -->


<pre style="background-color: #e0e0e0;">
<code class="language-text">
Markdown:
--------

&lt;!-- {maketoc Title=&quot;&quot;} --&gt;

---

#### SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)

Nature Immunology Sept 2023 https://doi.org/10.1038/s41590-023-01601-2

Amy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, Sara Cherry, Daniel S. Chertow, Helen E. Davies, Christopher L. Dupont, Steven G. Deeks, William Eimer, E. Wesley Ely, Alessio Fasano, Marcelo Freire, Linda N. Geng, Diane E. Griffin, Timothy J. Henrich, Akiko Iwasaki, David Izquierdo-Garcia, Michela Locci, Saurabh Mehandru, Mark M. Painter, Michael J. Peluso, …E. John Wherry 

##### Table of Contents

&lt;img src=&quot;/attachments/d3.mock.jpg&quot; alt=&quot;image&quot; width=&quot;600&quot;&gt;

Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the coronavirus SARS-CoV-2 after acute infection. Instead, replicating virus and/or viral RNA—potentially capable of being translated to produce viral proteins—persist in tissue as a ‘reservoir’. This reservoir could modulate host immune responses or release viral proteins into the circulation. Here we review studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in PASC samples. Mechanisms by which a SARS-CoV-2 reservoir may contribute to PASC pathology, including coagulation, microbiome and neuroimmune abnormalities, are delineated. We identify research priorities to guide the further study of a SARS-CoV-2 reservoir in PASC, with the goal that clinical trials of antivirals or other therapeutics with potential to clear a SARS-CoV-2 reservoir are accelerated.

##### Locations in the body

&lt;img src=&quot;/attachments/d3.mock.jpg&quot; alt=&quot;image&quot; width=&quot;900&quot;&gt;

##### Research suggesions

 **Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC** 

* Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? 

  * Is there a preference for persistence in certain cell or tissue types?

* Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?

* Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? 

  * Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? 

  * If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?

* Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?

* Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?

* Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?

* Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?

* Are neutralizing antibody responses qualitatively different in patients with PASC?

* By what mechanisms can SARS-CoV-2 evade immune detection? 

  * Do such mechanisms differ by cell or tissue type, or by viral variant? 

  * Do viral mutations and selection contribute to persistence?

* Can the spike protein travel via EVs into the bloodstream?

* Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?

* Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?

* Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?

* Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?

* Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?

  *  If so, is disruption a cause or consequence of PASC?

* Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? 

  * Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?

* Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?

 **[&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;Download the PDF from VitaminDWiki ](/attachments/d3.mock.pdf)** 

---

#### VitaminDWiki - &lt;a href=&quot;/posts/long-covid-is-now-the-biggest-covid-concern-many-studies&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Long-COVID is now the biggest COVID concern - many studies&quot;&gt;Long-COVID is now the biggest COVID concern - many studies&lt;/a&gt;

---

---

#### VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on

---

##### VitaminDWiki -  
&lt;!-- {SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL} --&gt;
       studies in both categories Virus and Vitamin D Receptor

This list is automatically updated

---

##### VitaminDWiki - [Vitamin D Receptor](/categories/vitamin-d-receptor) activation can be increased in 14 ways

 **[Resveratrol](/categories/resveratrol), &amp;nbsp;&lt;a href=&quot;/posts/overview-omega-3-many-benefits-include-helping-vitamin-domega-3&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Overview: Omega-3 many benefits include helping vitamin D|Omega-3&quot;&gt;Overview: Omega-3 many benefits include helping vitamin D|Omega-3&lt;/a&gt;, &amp;nbsp;&lt;a href=&quot;/posts/magnesium-and-vitamin-d-magnesium&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Magnesium and Vitamin D |Magnesium&quot;&gt;Magnesium and Vitamin D |Magnesium&lt;/a&gt;,&amp;nbsp; &lt;a href=&quot;/posts/zinc-and-vitamin-d-zinc&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Zinc and Vitamin D |Zinc&quot;&gt;Zinc and Vitamin D |Zinc&lt;/a&gt;, &amp;nbsp; &lt;a href=&quot;/posts/quercetin-flavonoid-helps-activate-the-vitamin-d-receptor-march-2016-quercetin&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin&quot;&gt;Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin&lt;/a&gt;, &amp;nbsp; &lt;a href=&quot;/posts/better-than-dailynon-daily-vit-d&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Better than Daily|non-daily Vit D&quot;&gt;Better than Daily|non-daily Vit D&lt;/a&gt;, &amp;nbsp;&lt;a href=&quot;/posts/curcumin-may-increase-vitamin-d-in-tissues-activates-vitamin-d-receptor-dec-2010curcumin&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin&quot;&gt;Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin&lt;/a&gt;, intense exercise, &lt;a href=&quot;/posts/14th-activator-of-the-vitamin-d-receptor-butyrate-from-gut-bacteria-or-supplement-butyrate&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: 14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate&quot;&gt;14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate&lt;/a&gt; &amp;nbsp; Ginger, &amp;nbsp; Essential oils, etc&amp;nbsp; Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators** 

&lt;!-- ~tc~ (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) ~/tc~ --&gt;


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)`
│   inner_content: `SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)`
│   │   inner_content: `SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)`├── TextNode
│   full_match: `\nNature Immunology Sept 2023 https://doi.org/10.1038/s41590-023-01601-2\nAmy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, Sara Cherry, Daniel S. Chertow, Helen E. Davies, Christopher L. Dupont, Steven G. Deeks, William Eimer, E. Wesley Ely, Alessio Fasano, Marcelo Freire, Linda N. Geng, Diane E. Griffin, Timothy J. Henrich, Akiko Iwasaki, David Izquierdo-Garcia, Michela Locci, Saurabh Mehandru, Mark M. Painter, Michael J. Peluso, …E. John Wherry \n`
│   inner_content: `\nNature Immunology Sept 2023 https://doi.org/10.1038/s41590-023-01601-2\nAmy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, Sara Cherry, Daniel S. Chertow, Helen E. Davies, Christopher L. Dupont, Steven G. Deeks, William Eimer, E. Wesley Ely, Alessio Fasano, Marcelo Freire, Linda N. Geng, Diane E. Griffin, Timothy J. Henrich, Akiko Iwasaki, David Izquierdo-Garcia, Michela Locci, Saurabh Mehandru, Mark M. Painter, Michael J. Peluso, …E. John Wherry \n`├── HeadingNode
│   full_match: `\n!!!!!Table of Contents`
│   inner_content: `Table of Contents`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Table of Contents`
│   │   inner_content: `Table of Contents`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20079&quot; width=&quot;600&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20079&quot; width=&quot;600&quot;
│   │   type: attId
│   │   attId: 20079
│   │   width: 600├── TextNode
│   full_match: `\n\nMillions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the coronavirus SARS-CoV-2 after acute infection. Instead, replicating virus and/or viral RNA—potentially capable of being translated to produce viral proteins—persist in tissue as a ‘reservoir’. This reservoir could modulate host immune responses or release viral proteins into the circulation. Here we review studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in PASC samples. Mechanisms by which a SARS-CoV-2 reservoir may contribute to PASC pathology, including coagulation, microbiome and neuroimmune abnormalities, are delineated. We identify research priorities to guide the further study of a SARS-CoV-2 reservoir in PASC, with the goal that clinical trials of antivirals or other therapeutics with potential to clear a SARS-CoV-2 reservoir are accelerated.\n`
│   inner_content: `\n\nMillions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the coronavirus SARS-CoV-2 after acute infection. Instead, replicating virus and/or viral RNA—potentially capable of being translated to produce viral proteins—persist in tissue as a ‘reservoir’. This reservoir could modulate host immune responses or release viral proteins into the circulation. Here we review studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in PASC samples. Mechanisms by which a SARS-CoV-2 reservoir may contribute to PASC pathology, including coagulation, microbiome and neuroimmune abnormalities, are delineated. We identify research priorities to guide the further study of a SARS-CoV-2 reservoir in PASC, with the goal that clinical trials of antivirals or other therapeutics with potential to clear a SARS-CoV-2 reservoir are accelerated.\n`├── HeadingNode
│   full_match: `!!!!!Locations in the body`
│   inner_content: `Locations in the body`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Locations in the body`
│   │   inner_content: `Locations in the body`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ImgNode
│   full_match: `{img type=&quot;attId&quot; attId=&quot;20080&quot; width=&quot;900&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  type=&quot;attId&quot; attId=&quot;20080&quot; width=&quot;900&quot;
│   │   type: attId
│   │   attId: 20080
│   │   width: 900├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── HeadingNode
│   full_match: `\n!!!!!Research suggesions`
│   inner_content: `Research suggesions`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `Research suggesions`
│   │   inner_content: `Research suggesions`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC__`
│   inner_content: `Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC`
│   children:
│   ├── TextNode
│   │   full_match: `Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC`
│   │   inner_content: `Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? `
│   inner_content: `Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? `
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? `
│   │   inner_content: `Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**Is there a preference for persistence in certain cell or tissue types?`
│   inner_content: `Is there a preference for persistence in certain cell or tissue types?`
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `Is there a preference for persistence in certain cell or tissue types?`
│   │   inner_content: `Is there a preference for persistence in certain cell or tissue types?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?`
│   inner_content: `Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?`
│   │   inner_content: `Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? `
│   inner_content: `Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? `
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? `
│   │   inner_content: `Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? `
│   inner_content: `Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? `
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? `
│   │   inner_content: `Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?`
│   inner_content: `If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?`
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?`
│   │   inner_content: `If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?`
│   inner_content: `Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?`
│   │   inner_content: `Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?`
│   inner_content: `Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?`
│   │   inner_content: `Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?`
│   inner_content: `Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?`
│   │   inner_content: `Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?`
│   inner_content: `Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?`
│   │   inner_content: `Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Are neutralizing antibody responses qualitatively different in patients with PASC?`
│   inner_content: `Are neutralizing antibody responses qualitatively different in patients with PASC?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Are neutralizing antibody responses qualitatively different in patients with PASC?`
│   │   inner_content: `Are neutralizing antibody responses qualitatively different in patients with PASC?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*By what mechanisms can SARS-CoV-2 evade immune detection? `
│   inner_content: `By what mechanisms can SARS-CoV-2 evade immune detection? `
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `By what mechanisms can SARS-CoV-2 evade immune detection? `
│   │   inner_content: `By what mechanisms can SARS-CoV-2 evade immune detection? `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**Do such mechanisms differ by cell or tissue type, or by viral variant? `
│   inner_content: `Do such mechanisms differ by cell or tissue type, or by viral variant? `
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `Do such mechanisms differ by cell or tissue type, or by viral variant? `
│   │   inner_content: `Do such mechanisms differ by cell or tissue type, or by viral variant? `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**Do viral mutations and selection contribute to persistence?`
│   inner_content: `Do viral mutations and selection contribute to persistence?`
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `Do viral mutations and selection contribute to persistence?`
│   │   inner_content: `Do viral mutations and selection contribute to persistence?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Can the spike protein travel via EVs into the bloodstream?`
│   inner_content: `Can the spike protein travel via EVs into the bloodstream?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Can the spike protein travel via EVs into the bloodstream?`
│   │   inner_content: `Can the spike protein travel via EVs into the bloodstream?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?`
│   inner_content: `Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?`
│   │   inner_content: `Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?`
│   inner_content: `Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?`
│   │   inner_content: `Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?`
│   inner_content: `Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?`
│   │   inner_content: `Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?`
│   inner_content: `Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?`
│   │   inner_content: `Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?`
│   inner_content: `Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?`
│   │   inner_content: `Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `** If so, is disruption a cause or consequence of PASC?`
│   inner_content: ` If so, is disruption a cause or consequence of PASC?`
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: ` If so, is disruption a cause or consequence of PASC?`
│   │   inner_content: ` If so, is disruption a cause or consequence of PASC?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? `
│   inner_content: `Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? `
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? `
│   │   inner_content: `Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? `├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `**Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?`
│   inner_content: `Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?`
│   depth: `2`
│   children:
│   ├── TextNode
│   │   full_match: `Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?`
│   │   inner_content: `Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?`
│   inner_content: `Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?`
│   │   inner_content: `Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── FontNode
│   full_match: `{FONT(size=&quot;20&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;20&quot;
│   │   size: 20
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 20078
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki - ((Long-COVID is now the biggest COVID concern - many studies))`
│   inner_content: `VitaminDWiki - ((Long-COVID is now the biggest COVID concern - many studies))`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - `
│   │   inner_content: `VitaminDWiki - `
│   ├── LocalLinkNode
│   │   full_match: `((Long-COVID is now the biggest COVID concern - many studies))`
│   │   inner_content: `Long-COVID is now the biggest COVID concern - many studies`
│   │   page: `Long-COVID is now the biggest COVID concern - many studies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Long-COVID is now the biggest COVID concern - many studies`
│   │   │   inner_content: `Long-COVID is now the biggest COVID concern - many studies`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── IncludeNode
│   full_match: `{include page=&quot;Half as much Long-Haul with Omicron - June 2022 &quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Half as much Long-Haul with Omicron - June 2022 &quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Half as much Long-Haul with Omicron - June 2022 
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on`
│   inner_content: `VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on`
│   │   inner_content: `VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!VitaminDWiki -  {SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL}       studies in both categories Virus and Vitamin D Receptor`
│   inner_content: `VitaminDWiki -  {SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL}       studies in both categories Virus and Vitamin D Receptor`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki -  `
│   │   inner_content: `VitaminDWiki -  `
│   ├── SqlNode
│   │   full_match: `{SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL}`
│   │   inner_content: `SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;`
│   │   attrs_dict:
│   │   │   raw_content: db=&gt;vitamind
│   │   │   db: &gt;vitamind
│   ├── TextNode
│   │   full_match: `       studies in both categories Virus and Vitamin D Receptor`
│   │   inner_content: `       studies in both categories Virus and Vitamin D Receptor`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;This list is automatically updated&#39;&#39;`
│   inner_content: `This list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `This list is automatically updated`
│   │   inner_content: `This list is automatically updated`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── CategoryNode
│   full_match: `{category id=&quot;142+155&quot; types=&quot;wiki&quot; sort=&quot;created_desc&quot; split=&quot;n&quot; and=&quot;y&quot; sub=&quot;n&quot;- showdescription=&quot;n&quot; showname=&quot;y&quot; showtype=&quot;n&quot; one=&quot;y&quot; showTitle=&quot;n&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content: id=&quot;142+155&quot; types=&quot;wiki&quot; sort=&quot;created_desc&quot; split=&quot;n&quot; and=&quot;y&quot; sub=&quot;n&quot;- showdescription=&quot;n&quot; showname=&quot;y&quot; showtype=&quot;n&quot; one=&quot;y&quot; showTitle=&quot;n&quot;
│   │   id: 142+155
│   │   types: wiki
│   │   sort: created_desc
│   │   split: n
│   │   and: y
│   │   sub: n
│   │   showdescription: n
│   │   showname: y
│   │   showtype: n
│   │   one: y
│   │   showTitle: n├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!!VitaminDWiki - ((Vitamin D Receptor)) activation can be increased in 14 ways`
│   inner_content: `VitaminDWiki - ((Vitamin D Receptor)) activation can be increased in 14 ways`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - `
│   │   inner_content: `VitaminDWiki - `
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D Receptor))`
│   │   inner_content: `Vitamin D Receptor`
│   │   page: `Vitamin D Receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D Receptor`
│   │   │   inner_content: `Vitamin D Receptor`
│   ├── TextNode
│   │   full_match: ` activation can be increased in 14 ways`
│   │   inner_content: ` activation can be increased in 14 ways`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__((Resveratrol)), ~hs~((Overview: Omega-3 many benefits include helping vitamin D|Omega-3)), ~hs~((Magnesium and Vitamin D |Magnesium)),~hs~ ((Zinc and Vitamin D |Zinc)), ~hs~ ((Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin)), ~hs~ ((Better than Daily|non-daily Vit D)), ~hs~((Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin)), intense exercise, ((14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate)) ~hs~ Ginger, ~hs~ Essential oils, etc~hs~ Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators__`
│   inner_content: `((Resveratrol)), ~hs~((Overview: Omega-3 many benefits include helping vitamin D|Omega-3)), ~hs~((Magnesium and Vitamin D |Magnesium)),~hs~ ((Zinc and Vitamin D |Zinc)), ~hs~ ((Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin)), ~hs~ ((Better than Daily|non-daily Vit D)), ~hs~((Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin)), intense exercise, ((14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate)) ~hs~ Ginger, ~hs~ Essential oils, etc~hs~ Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Resveratrol))`
│   │   inner_content: `Resveratrol`
│   │   page: `Resveratrol`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Resveratrol`
│   │   │   inner_content: `Resveratrol`
│   ├── TextNode
│   │   full_match: `, `
│   │   inner_content: `, `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── LocalLinkNode
│   │   full_match: `((Overview: Omega-3 many benefits include helping vitamin D|Omega-3))`
│   │   inner_content: `Overview: Omega-3 many benefits include helping vitamin D|Omega-3`
│   │   page: `Overview: Omega-3 many benefits include helping vitamin D|Omega-3`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Overview: Omega-3 many benefits include helping vitamin D|Omega-3`
│   │   │   inner_content: `Overview: Omega-3 many benefits include helping vitamin D|Omega-3`
│   ├── TextNode
│   │   full_match: `, `
│   │   inner_content: `, `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── LocalLinkNode
│   │   full_match: `((Magnesium and Vitamin D |Magnesium))`
│   │   inner_content: `Magnesium and Vitamin D |Magnesium`
│   │   page: `Magnesium and Vitamin D |Magnesium`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Magnesium and Vitamin D |Magnesium`
│   │   │   inner_content: `Magnesium and Vitamin D |Magnesium`
│   ├── TextNode
│   │   full_match: `,`
│   │   inner_content: `,`
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LocalLinkNode
│   │   full_match: `((Zinc and Vitamin D |Zinc))`
│   │   inner_content: `Zinc and Vitamin D |Zinc`
│   │   page: `Zinc and Vitamin D |Zinc`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Zinc and Vitamin D |Zinc`
│   │   │   inner_content: `Zinc and Vitamin D |Zinc`
│   ├── TextNode
│   │   full_match: `, `
│   │   inner_content: `, `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LocalLinkNode
│   │   full_match: `((Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin))`
│   │   inner_content: `Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin`
│   │   page: `Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin`
│   │   │   inner_content: `Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin`
│   ├── TextNode
│   │   full_match: `, `
│   │   inner_content: `, `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── LocalLinkNode
│   │   full_match: `((Better than Daily|non-daily Vit D))`
│   │   inner_content: `Better than Daily|non-daily Vit D`
│   │   page: `Better than Daily|non-daily Vit D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Better than Daily|non-daily Vit D`
│   │   │   inner_content: `Better than Daily|non-daily Vit D`
│   ├── TextNode
│   │   full_match: `, `
│   │   inner_content: `, `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── LocalLinkNode
│   │   full_match: `((Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin))`
│   │   inner_content: `Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin`
│   │   page: `Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin`
│   │   │   inner_content: `Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin`
│   ├── TextNode
│   │   full_match: `, intense exercise, `
│   │   inner_content: `, intense exercise, `
│   ├── LocalLinkNode
│   │   full_match: `((14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate))`
│   │   inner_content: `14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate`
│   │   page: `14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate`
│   │   │   inner_content: `14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate`
│   ├── TextNode
│   │   full_match: ` `
│   │   inner_content: ` `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── TextNode
│   │   full_match: ` Ginger, `
│   │   inner_content: ` Ginger, `
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── TextNode
│   │   full_match: ` Essential oils, etc`
│   │   inner_content: ` Essential oils, etc`
│   ├── HorizontalSpaceNode
│   │   full_match: `~hs~`
│   │   inner_content: ``
│   │   repetitions: `1`
│   ├── TextNode
│   │   full_match: ` Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators`
│   │   inner_content: ` Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── TikiCommentNode
│   full_match: `~tc~ (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) ~/tc~`
│   inner_content: ` (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) `
│   children:
│   ├── TextNode
│   │   full_match: ` (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) `
│   │   inner_content: ` (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) `

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Nature Immunology Sept 2023 https://doi.org/10.1038/s41590-023-01601-2
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, Katie Bach, Brittany P. Boribong, Marcus Buggert, Sara Cherry, Daniel S. Chertow, Helen E. Davies, Christopher L. Dupont, Steven G. Deeks, William Eimer, E. Wesley Ely, Alessio Fasano, Marcelo Freire, Linda N. Geng, Diane E. Griffin, Timothy J. Henrich, Akiko Iwasaki, David Izquierdo-Garcia, Michela Locci, Saurabh Mehandru, Mark M. Painter, Michael J. Peluso, …E. John Wherry 

!!!!!Table of Contents
{img type=&quot;attId&quot; attId=&quot;20079&quot; width=&quot;600&quot;}

Millions of people are suffering from Long COVID or post-acute sequelae of COVID-19 (PASC). Several biological factors have emerged as potential drivers of PASC pathology. Some individuals with PASC may not fully clear the coronavirus SARS-CoV-2 after acute infection. Instead, replicating virus and/or viral RNA—potentially capable of being translated to produce viral proteins—persist in tissue as a ‘reservoir’. This reservoir could modulate host immune responses or release viral proteins into the circulation. Here we review studies that have identified SARS-CoV-2 RNA/protein or immune responses indicative of a SARS-CoV-2 reservoir in PASC samples. Mechanisms by which a SARS-CoV-2 reservoir may contribute to PASC pathology, including coagulation, microbiome and neuroimmune abnormalities, are delineated. We identify research priorities to guide the further study of a SARS-CoV-2 reservoir in PASC, with the goal that clinical trials of antivirals or other therapeutics with potential to clear a SARS-CoV-2 reservoir are accelerated.
!!!!!Locations in the body
{img type=&quot;attId&quot; attId=&quot;20080&quot; width=&quot;900&quot;}

!!!!!Research suggesions
__Major areas of opportunity for research into a SARS-CoV-2 reservoir in PASC__
*Which PASC cell and tissue types harbor SARS-CoV-2 RNA or protein? 
**Is there a preference for persistence in certain cell or tissue types?
*Is SARS-CoV-2 RNA identified in PASC samples transcriptionally active, translating, replicating or infectious?
*Is the presence of a SARS-CoV-2 reservoir sufficient to drive PASC symptoms? 
**Are SARS-CoV-2 RNA and proteins also identified in samples collected from post-COVID-19 individuals without PASC? 
**If yes, what factors differentiate SARS-CoV-2 persistence in PASC from persistence in asymptomatic individuals?
*Do particular classes of symptoms tend to be driven by the location of the reservoir—for example, dyspnea from a lung reservoir or gastrointestinal symptoms from a gut reservoir?
*Do measurements of SARS-CoV-2 protein or antibody responses in body fluids correlate with SARS-COV-2 persistence in tissue?
*Can the transcriptional program of circulating immune cells be used as a biosensor of SARS-CoV-2 persistence in tissue?
*Does T cell exhaustion correlate with SARS-CoV-2 persistence in PASC?
*Are neutralizing antibody responses qualitatively different in patients with PASC?
*By what mechanisms can SARS-CoV-2 evade immune detection? 
**Do such mechanisms differ by cell or tissue type, or by viral variant? 
**Do viral mutations and selection contribute to persistence?
*Can the spike protein travel via EVs into the bloodstream?
*Does a SARS-CoV-2 reservoir or protein contribute to fibrin/ amyloid microclotting, platelet activation or related vasculature issues in PASC?
*Does a SARS-CoV-2 reservoir in PASC correlate with the reactivation of other pathogens such as herpesviruses?
*Does a SARS-CoV-2 reservoir in PASC correlate with changes in human endogenous retrovirus activity?
*Can a SARS-CoV-2 reservoir alter the local transcriptome or epigenome?
*Does a SARS-CoV-2 reservoir in PASC correlate with the disruption of microbiome composition or activity?
** If so, is disruption a cause or consequence of PASC?
*Is a SARS-CoV-2 reservoir associated with host epithelial barrier breakdown in PASC? 
**Does this facilitate the translocation viral protein or bacterial/fungal organisms into blood?
*Can SARS-CoV-2 persistence or the reactivation of other latent pathogens lead to cross-reactive antibody responses in PASC blood or tissue?
{FONT(size=&quot;20&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;20078&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!VitaminDWiki - ((Long-COVID is now the biggest COVID concern - many studies))
---
{include page=&quot;Half as much Long-Haul with Omicron - June 2022 &quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
---
!!!!VitaminDWiki comment: Virus protects itself by turning off the Vitamin D Receptor - which can be easily turned back on
---
!!!!!VitaminDWiki -  {SQL(db=&gt;vitamind)}SELECT COUNT(*) FROM (SELECT catObjectId, COUNT(*) FROM `tiki_category_objects` WHERE categId = 142  OR categId = 155 GROUP BY catObjectId HAVING COUNT(*) &gt; 1) AS categs INNER JOIN tiki_objects ON tiki_objects.objectId = categs.catObjectId WHERE type = &quot;wiki page&quot;{SQL}       studies in both categories Virus and Vitamin D Receptor
&#39;&#39;This list is automatically updated&#39;&#39;
{category id=&quot;142+155&quot; types=&quot;wiki&quot; sort=&quot;created_desc&quot; split=&quot;n&quot; and=&quot;y&quot; sub=&quot;n&quot;- showdescription=&quot;n&quot; showname=&quot;y&quot; showtype=&quot;n&quot; one=&quot;y&quot; showTitle=&quot;n&quot;}
---
!!!!!VitaminDWiki - ((Vitamin D Receptor)) activation can be increased in 14 ways
__((Resveratrol)), ~hs~((Overview: Omega-3 many benefits include helping vitamin D|Omega-3)), ~hs~((Magnesium and Vitamin D |Magnesium)),~hs~ ((Zinc and Vitamin D |Zinc)), ~hs~ ((Quercetin (flavonoid) helps activate the Vitamin D receptor – March 2016| Quercetin)), ~hs~ ((Better than Daily|non-daily Vit D)), ~hs~((Curcumin may increase Vitamin D in tissues (activates Vitamin D Receptor) – Dec 2010|Curcumin)), intense exercise, ((14th activator of the Vitamin D Receptor – Butyrate (from gut bacteria, or supplement) |Butyrate)) ~hs~ Ginger, ~hs~ Essential oils, etc~hs~ Note: The founder of VitaminDWiki uses 10 of the 14 known VDR activators__
~tc~ (alias(Long-COVID can hide for years in hundreds of different places in the body – Sept 2023)) ~/tc~
</code>
</pre>
